Effect of Exercise on Appetite in Response to Meals During Energy Restriction

ConditionHealthy
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age18-65
SponsorUniversity of Glasgow

About this trial

This study's primary aim is to investigate the acute effect of an exercise bout (30 minutes) on appetite and appetite-regulatory hormone responses during energy restriction. The researchers will also test if the exercise bout influences ad libitum energy intake after a period of energy restriction.

The researchers will compare three groups (control, severe-energy restriction, and severe-energy restriction with exercise) to see if exercise bout, during energy restriction, affects appetite, appetite-regulatory hormones, and energy intake in healthy men.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Males aged 18 years or older.

Have stable body mass for at least six months (within ±2 kg).

Disqualifiers

Females

People who are younger than 18 or older than 65 years old.

Following a special diet (e.g. weight loss, vegetarian or vegan, etc.).

Have food allergies related to the study.

Trial design

Design model

Crossover

Treatments tested in this trial

  • Severe-energy restriction

    Other intervention

    The participants will receive only 25% of their estimated energy needs.

  • Severe-energy restriction with exercise

    Other intervention

    The participants will run on the treadmill for 30 minutes and receive 25% of their estimated energy needs.

Treatment groups

14 Participants
are divided into 3 treatment groups
Group A: ControlNo intervention 0 interventions
Group B: Severe-energy restrictionExperimental treatment 1 intervention
Group C: Severe-energy restriction with exerciseExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Change in Peptide-YY (PYY)

The researchers will draw blood samples at different time points during the trial to measure the change in PYY blood levels. Area under the plasma concentration versus time curve (AUC) of PYY will be calculated using the trapezoidal rule.

Time frame
At 0 (baseline), 0.5, 1, 1.5, 2, 3, 4, 5, 5.5, 6, 6.5, 7, and 23 hours
2

Change in Ghrelin

The researchers will draw blood samples at different time points during the trial to measure the change in ghrelin blood levels. Area under the plasma concentration versus time curve (AUC) of ghrelin will be calculated using the trapezoidal rule.

Time frame
At 0 (baseline), 0.5, 1, 1.5, 2, 3, 4, 5, 5.5, 6, 6.5, 7, and 23 hours
3

Change in Glucagon-Like Peptide-1 (GLP-1)

The researchers will draw blood samples at different time points during the trial to measure the change in GLP-1 blood levels. Area under the plasma concentration versus time curve (AUC) of GLP-1 will be calculated using the trapezoidal rule.

Time frame
At 0 (baseline), 0.5, 1, 1.5, 2, 3, 4, 5, 5.5, 6, 6.5, 7, and 23 hours
4

Change in subjective appetite sensations

The researchers will assess the subjective appetite sensations using 100 mm visual analog scales (VAS) to measure appetite sensations (hunger, satiety, fullness, prospective food consumption, and desire to eat). The VAS are 100 mm long, with words anchored at each end expressing the most positive and negative ratings. Scores for each appetite construct range from 0-100.

Time frame
At 0 (baseline), 0.5, 1, 1.5, 2, 2.5, 3, 4, 5, 5.5, 6, 6.5, 7, 23, 24, and 25 hours

Secondary outcomes

1

Energy Intake

To determine the amount of each food item consumed, the researchers will measure the difference in weight between before and after the meal. The researchers will use manufacturer details to determine energy consumption.

Time frame
At 24 hours
2

Macro-nutrient Intake

To determine the amount of each food item consumed, the researchers will measure the difference in weight between before and after the meal. The researchers will use manufacturer details to determine macro-nutrient consumption.

Time frame
At 24 hours

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Glasgow

Lead sponsor

Northern Border University

Collaborator